Ian has more than 25 years of experience in the pharmaceutical industry, gained through senior positions in sales, marketing, business development & licensing in both multinational companies and biotech. Through Atebion BDS, he assists spin-outs, BioTech and Major Pharmaceutical Companies in their strategic investment decisions.
Read More →
